Labori- ja patoloogiateenuste ostmine

Mandatory: ISO 15189-accredited medical laboratory able to supply molecular-genetic, pharmacogenetic and cytogenetic tests for one year, priced no worse than your standard/planned-SHIF rates, plus you must certify <10 % of contract value goes to Russian-linked subcontractors; bid only if you already hold valid ISO 15189 scope covering these tests and can document non-Russian supply chain.

This short document is simply the blank “Criterion Question Form (Form 1)” that the hospital will later populate with qualification questions; it contains no actual requirements, evaluation criteria or mandatory conditions, so bidders should wait for the full tender dossier before deciding to bid.

The hospital is buying 1-year of laboratory/pathology services and will exclude any bidder that cannot confirm—via the yes/no checklist in “Vorm 2”—that it already holds (or can obtain) an Estonian health-care provider licence, ISO 15189 or equivalent lab accreditation, and the capacity to deliver at prices/terms no worse than those it offers under the national insurance scheme.

Form 3 is an empty criterion-questionnaire template (no questions or requirements listed), so bidders must wait for the full tender documents to assess mandatory conditions, qualifications or evaluation rules before deciding whether to pursue the one-year laboratory and pathology services contract.

To win this 1-year laboratory and pathology-services contract with West-Tallinn Central Hospital, bidders must (1) quote the largest percentage discount off the Estonian Health Insurance Fund price list (70–90 % of total score), (2) prove electronic data exchange via Medipost protocol (10 %), and (3) show active research co-operation on Estonian genetic diseases with the hospital (20 %, mandatory for genetics/cytogenetics lots)—so only labs that already integrate Medipost and collaborate academically should bid.

AS Lääne-Tallinna Keskhaigla otsib 1-aastaseks perioodiks labori- ja patoloogiateenuse osutajaid, kes peavad (kohustuslikult) tagama plaaniliste uuringute hinnad ja tingimused vähemalt samal tasemel nagu riikliku tervisekindlustuse alusel tavapäraselt pakutakse ning vajadusel nõustama tellijat uuringute valikul ja tõlgendamisel; pakkumusi võib esitada kuni 21 osas.

AS Lääne-Tallinna Keskhaigla otsib akrediteeritud meditsiinilaborit, kes üheks aastaks osutaks kõiki tellitavaid labori- ja patoloogiateenuseid Eesti tavapärase kvaliteedi, riikliku tervisekindlustuse hinnataset mitte-ületavate hindade, eestikeelsete kliiniliselt informatiivsete raportite ning sama kiirete ooteaegadega nagu oma patsientidele (kohustuslikud nõuded: akrediteering, valdkonnaspetsialistide poolt tehtavad tsütogeneetika/geneetika/patoloogia uuringud ja farmakogeneetika detailne ravimi annustamissoovitustega aruanne).

This one-year framework agreement requires (mandatory) medical laboratory service providers to offer hospital-grade tests at prices/conditions no worse than their standard offerings—including to national-health-insurance clients—and to give clinical advice on test selection and interpretation; bidders must therefore be certified health-care laboratories with capacity for prompt, high-volume testing and documented equal-or-better pricing policies.

This data-processing addendum (mandatory for any bidder) merely spells out GDPR-compliant handling of patient data when the hospital outsources lab tests—no pricing, capacity, or medical-lab qualifications are mentioned.

The hospital is seeking qualified medical laboratories (mandatory: licensed/accredited for clinical/pathology services) to supply on-call lab and pathology tests for one year at terms no worse than those offered to any other buyer, including under the national health-insurance scheme, and to advise on test selection and interpretation—bid only if you meet these service-level and pricing requirements.